Related Experiment Video
Updated: Sep 17, 2025
06:11
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
Published on: April 20, 2018
9.9K
Health-Related Quality of Life in Patients With a Head and Neck Sarcoma: A Mixed-Methods Study
E Koffi1,2,3, C S Padilla3,4, C Drabbe5
1Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Head & Neck
|June 30, 2025
Summary
Head and neck sarcomas (HNS) patients experience significant fatigue and speaking difficulties. Tailored HRQoL assessments are crucial for addressing unique challenges like impaired tongue mobility.
Area of Science:
- Oncology
- Quality of Life Research
- Patient-Reported Outcomes
Background:
- Head and neck sarcomas (HNS) are rare, presenting unique health-related quality of life (HRQoL) challenges.
- Understanding the prevalence of generic and location-specific HRQoL issues is vital for patient care.
Purpose of the Study:
- To examine and identify the prevalence of generic and location-specific HRQoL issues in HNS patients.
- To inform comprehensive HRQoL assessment strategies for HNS.
Main Methods:
- Quantitative analysis of data from 72 HNS survivors (SURVSARC study).
- Qualitative thematic analysis of data from 18 HNS patients (EORTC QoL VOICE study).
Main Results:
- Common issues include fatigue (68%), speaking difficulties (50%), and dry mouth (48%).
- Qualitative data revealed HNS-specific problems: throat pain, impaired tongue mobility, and facial/neck swelling.
Conclusions:
- HNS patients share some symptoms with other cancers, but location-specific issues require tailored measurement.
- A combination of generic, location-specific, and HNS-specific assessments offers comprehensive HRQoL evaluation.
Related Concept Videos
01:21Cancer Survival Analysis
458
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
458
01:24Kaplan-Meier Approach
277
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
277